Home > Qtrly Results > BIOCON

BIOCON
Quarterly Results Analysis [Dec2024]

BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Revenues ₹3,821 Cr ₹3,590 Cr ₹3,433 Cr ₹3,917 Cr ₹3,954 Cr ₹3,462 Cr ₹3,423 Cr ₹3,774 Cr
Expenses ₹3,070 Cr ₹2,905 Cr ₹2,813 Cr ₹3,001 Cr ₹3,027 Cr ₹2,721 Cr ₹2,708 Cr ₹2,777 Cr
Operating Income ₹752 Cr ₹685 Cr ₹620 Cr ₹916 Cr ₹927 Cr ₹742 Cr ₹714 Cr ₹997 Cr
Other Income ₹35 Cr ₹33 Cr ₹1,135 Cr ₹49 Cr ₹566 Cr ₹158 Cr ₹94 Cr ₹155 Cr
Interest ₹223 Cr ₹226 Cr ₹236 Cr ₹227 Cr ₹267 Cr ₹248 Cr ₹233 Cr ₹249 Cr
Depreciation ₹425 Cr ₹420 Cr ₹405 Cr ₹407 Cr ₹415 Cr ₹389 Cr ₹358 Cr ₹364 Cr
Profit Before Tax ₹156 Cr ₹98 Cr ₹1,146 Cr ₹322 Cr ₹832 Cr ₹239 Cr ₹217 Cr ₹537 Cr
Profit After Tax ₹81 Cr ₹27 Cr ₹862 Cr ₹226 Cr ₹777 Cr ₹197 Cr ₹182 Cr ₹455 Cr
EPS ₹0.21 ₹-0.13 ₹5.49 ₹1.13 ₹5.50 ₹1.05 ₹0.84 ₹2.61
Industry Peers & Returns1W1M1Y
BIOCON -2.6% 8.7% 33%
SUN PHARMACEUTICAL INDUSTRIES -3.9% 3% 7.9%
DIVIS LABORATORIES -5% -1.1% 71.6%
CIPLA -4.4% 0.2% -1.7%
TORRENT PHARMACEUTICALS -1.6% 6.5% 26.2%
DR REDDYS LABORATORIES -2.4% 2.4% -5.4%
MANKIND PHARMA 2.4% 7.1% 3.9%
ZYDUS LIFESCIENCES -3.3% -1% -11.4%
LUPIN -5.4% 3.4% 26.8%

BIOCON Quarterly Revenues

Revenues
Q-o-Q

6.43 %

Y-o-Y

-3.35 %

Quarters Revenues % Change
Dec2024 ₹3,821 Cr
6.43
Sep2024 ₹3,590 Cr
4.59
Jun2024 ₹3,433 Cr
-12.36
Mar2024 ₹3,917 Cr
-0.93
Dec2023 ₹3,954 Cr
14.19
Sep2023 ₹3,462 Cr
1.16
Jun2023 ₹3,423 Cr
-9.31
Mar2023 ₹3,774 Cr -

BIOCON Quarterly Operating Profit

Operating Profit
Q-o-Q

9.69 %

Y-o-Y

-18.88 %

Quarters Operating Profit % Change
Dec2024 ₹752 Cr
9.69
Sep2024 ₹685 Cr
10.48
Jun2024 ₹620 Cr
-32.26
Mar2024 ₹916 Cr
-1.18
Dec2023 ₹927 Cr
24.97
Sep2023 ₹742 Cr
3.81
Jun2023 ₹714 Cr
-28.37
Mar2023 ₹997 Cr -
Operating Margins
Q-o-Q

3.04 %

Y-o-Y

-16.08 %

Quarters Operating Margin% % Change
Dec2024 19.67%
3.04
Sep2024 19.09%
5.64
Jun2024 18.07%
-22.71
Mar2024 23.38%
-0.26
Dec2023 23.44%
9.43
Sep2023 21.42%
2.64
Jun2023 20.87%
-21.04
Mar2023 26.43% -

BIOCON Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

199.26 %

Y-o-Y

-89.57 %

Quarters Profit After Tax % Change
Dec2024 ₹81 Cr
199.26
Sep2024 ₹27 Cr
-96.86
Jun2024 ₹862 Cr
282.00
Mar2024 ₹226 Cr
-70.98
Dec2023 ₹777 Cr
294.82
Sep2023 ₹197 Cr
8.13
Jun2023 ₹182 Cr
-59.94
Mar2023 ₹455 Cr -
PAT Margins
Q-o-Q

182.67 %

Y-o-Y

-89.22 %

Quarters PAT Margin(%) % Change
Dec2024 2.12 %
182.67
Sep2024 0.75 %
-97.01
Jun2024 25.1 %
335.76
Mar2024 5.76 %
-70.70
Dec2023 19.66 %
245.52
Sep2023 5.69 %
6.95
Jun2023 5.32 %
-55.85
Mar2023 12.05 % -

BIOCON Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Positive

Y-o-Y

-96.18 %

Quarters EPS % Change
Dec2024 ₹0.21
Positive
Sep2024 ₹-0.13
Negative
Jun2024 ₹5.49
385.84
Mar2024 ₹1.13
-79.45
Dec2023 ₹5.5
423.81
Sep2023 ₹1.05
25.00
Jun2023 ₹0.84
-67.82
Mar2023 ₹2.61 -

You may also like the below Video Courses